1-8 of 8
Harish Kumar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Arginine Methyltransferase PRMT5 Regulates Maintenance and TKI Resistance of Self-Renewing FLT3-ITD AML LSC

Harish Kumar, Mostafa Mohamed, Aditi Dhir, George M Burslem, Xinyang Zhao, Rui Lu, Erin Ahn, Ravi Bhatia
Journal: Blood
Blood (2024) 144 (Supplement 1): 1391.
https://doi.org/10.1182/blood-2024-205644
Published: 2024
Journal Articles

Single-Cell Multi-Ome Analysis Reveals Novel Molecular Mechanisms Underlying Subclonal Response to Survivin Inhibition in Relapsed/Refractory Multiple Myeloma

Atonu Chakrabortty, Harish Kumar, Jeremiah Pfitzer, Neeraj Sharma, Razan Waliagha, Ujjal Mukherjee, Shaji Kunnathu Kumar, Linda Banovic Baughn, Brian Van Ness, Amit K Mitra
Journal: Blood
Blood (2023) 142 (Supplement 1): 6616.
https://doi.org/10.1182/blood-2023-190442
Published: 2023
Journal Articles

The Anti-Leprosy Agent Clofazimine Inhibits FLT3-ITD Mutant AML Stem Cells and Potently Enhances Effects of TKI

Harish Kumar, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Sabyasachi Sanyal, Ravi Bhatia
Journal: Blood
Blood (2022) 140 (Supplement 1): 11533–11534.
https://doi.org/10.1182/blood-2022-169220
Published: 2022
Journal Articles

PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Harish Kumar, Aditi Dhir, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Xinyang Zhao, Rui Lu, Ravi Bhatia
Journal: Blood
Blood (2022) 140 (Supplement 1): 3073–3074.
https://doi.org/10.1182/blood-2022-168326
Published: 2022
Journal Articles

The Anti-Leprosy Drug Clofazimine Synergizes with BTK Inhibitors and Proteasome Inhibitors in Drug-Resistant Mantle Cell Lymphoma

Sayak Chakravarti, Harish Kumar, Suman Mazumder, Sabyasachi Sanyal, Brian G. Van Ness, Amit Kumar Mitra
Journal: Blood
Blood (2021) 138 (Supplement 1): 1190.
https://doi.org/10.1182/blood-2021-154377
Published: 2021
Journal Articles

Establishing a Novel Pipeline That Combines in-Silico Prediction with in-Vitro and Ex-Vivo V alidation to Discover Secondary Drug Combinations Against Relapsed and/or Refractory Multiple Myeloma

Sayak Chakravarti, Suman Mazumder, Harish Kumar, Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji Kumar, Linda B Baughn, Brian G. Van Ness, Amit Kumar Mitra
Journal: Blood
Blood (2021) 138 (Supplement 1): 1615.
https://doi.org/10.1182/blood-2021-154521
Published: 2021
Journal Articles

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Suman Mazumder, PhD, Sabyasachi Sanyal, PhD, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 4418.
https://doi.org/10.1182/blood-2019-131596
Published: 2019
Journal Articles

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Li Chen, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5543.
https://doi.org/10.1182/blood-2019-131923
Published: 2019